HIV drug combo tested in 15 healthy volunteers
NCT ID NCT07002242
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 trial tested how the HIV drug azvudine (FNC) interacts with another HIV drug, Aluvia (lopinavir/ritonavir), in 15 healthy adults. Participants took the drugs alone and together over three 5-day cycles. The goal was to measure drug levels in the blood and check for side effects, to see if the combination could be used safely in future HIV treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Azvudine (FNC) and Aluvia (lopinavir/ritonavir)
What this could lead to
If successful, this could help doctors understand how to combine these two HIV drugs safely and effectively.
What could go wrong
This is a very early, small study in healthy people, not patients. It only looks at drug levels and safety, not whether the combination works against HIV or COVID-19.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin People's Hospital
Tianjin, China